Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial

Metwally M. A. Hassan; Jansen J. A.; Overgaard J.

首页> 外文期刊>Clinical oncology >Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial

【24h】

Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial

机译：DAHANCA-5试验治疗的头颈部癌患者体内硝莫拉唑的群体药代动力学特征研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To study the pharmacokinetic characteristics of the hypoxic radiosensitiser nimorazole in patients with head and neck squamous cell carcinoma.

机译：目的：研究缺氧放射增敏剂尼莫拉唑在头颈部鳞状细胞癌患者中的药代动力学特征。

著录项

来源
《Clinical oncology》 |2015年第3期|共8页
作者
Metwally M. A. Hassan; Jansen J. A.; Overgaard J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Head and neck carcinoma; hypoxic radiosensitisation; nimorazole; pharmacokinetics; toxicity;

机译：头颈癌;低氧放射增敏;尼莫拉唑;药代动力学;毒性;
入库时间 2022-08-18 09:34:25

相似文献

外文文献
中文文献
专利

1. Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial [J] . Metwally M. A. Hassan, Jansen J. A., Overgaard J. Clinical oncology . 2015,第3期

机译：DAHANCA-5试验治疗的头颈部癌患者体内硝莫拉唑的群体药代动力学特征研究
2. Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy?(PRESTO trial) [J] . Margot Baudelet, Leen Van den Steen, Fréderic Duprez, Trials . 2020,第1期

机译：用于随机对照试验的研究方案：用（Chemo）放射治疗的头颈癌症患者预防吞咽锻炼？（Presto试验）
3. Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer [J] . Daniel A. Hamstra, Avraham Eisbruch, Maddireddy U.R. Naidu, Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第9期

机译：MRX-1024在头颈癌放疗或不放化疗中的药代动力学分析和1期研究
4. Microbiome of Saliva in Radiotherapy Treated Head and Neck Cancer Patients [C] . Sue Yom, John Witte, Li Zhang, International Molecular Medicine Tri-Conference. . 2016

机译：放疗头颈癌症患者的唾液微生物组
5. Toward Developing Pharmacokinetic Response Criteria to Chemoradiation in Head and Neck Cancer Patients Using Dynamic Contrast-Enhanced MRI. [D] . Onxley, Jennifer Dixon. 2012

机译：利用动态对比增强MRI制定针对头颈癌患者化学放疗的药代动力学反应标准。
6. Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial) [O] . Margot Baudelet, Leen Van den Steen, Fréderic Duprez, 2020

机译：一项随机对照试验的研究方案：接受（化学）放射疗法治疗的头颈癌患者的预防性吞咽运动（PRESTO试验）
7. Pharmacokinetic Analysis and Phase 1 Study of MRX-1024 in Patients Treated with Radiation Therapy with or without Cisplatinum for Head and Neck Cancer [O] . Daniel A. Hamstra, Avraham Eisbruch, Maddireddy U.R. Naidu, 2010

机译：患有或不含顺平面患者的患者MRX-1024的药代动力学分析及阶段1研究

Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial

摘要

著录项

相似文献

相关主题

期刊订阅